E
Waldencast plc WALD
$1.58 $0.128.22% NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

Company Overview

Waldencast plc is a publicly traded beauty and personal care company operating in the prestige and dermatologist-grade segments of the global beauty industry. The company focuses on developing, acquiring, and scaling high-growth consumer brands with differentiated positioning in skincare and color cosmetics. Its primary revenue drivers are its two core brands, Milk Makeup and Obagi Skincare, which collectively address both consumer-facing prestige beauty and physician-dispensed professional skincare markets.

The company was formed in 2020 and became publicly listed in 2021 following a business combination with a special purpose acquisition company, marking its transition into a standalone operating holding company. Waldencast’s strategy centers on brand-led growth, clinical credibility, and omnichannel distribution, positioning the company at the intersection of dermatological science, clean beauty, and influencer-driven consumer engagement.

Business Operations

Waldencast operates through two principal business segments: Milk Makeup, a prestige color cosmetics and skincare brand known for vegan and cruelty-free formulations, and Obagi Skincare, a professional-grade skincare brand with a strong presence in dermatology and medical aesthetics. Revenue is generated through direct-to-consumer e-commerce, specialty beauty retail partners, and professional medical channels, particularly for Obagi’s physician-dispensed products.

Operations span both domestic and international markets, with centralized brand management and shared corporate services supporting marketing, supply chain, and product innovation. The company controls its brand intellectual property and product development pipelines while leveraging third-party manufacturing and global distribution partners. Waldencast does not report material joint ventures but operates through wholly owned subsidiaries aligned to its brand portfolio.

Strategic Position & Investments

Waldencast’s strategic direction emphasizes organic brand expansion, international market penetration, and selective acquisitions within the prestige beauty and dermatological skincare categories. The company has invested in expanding Obagi Skincare’s clinical portfolio and professional education platforms while scaling Milk Makeup through new product launches and broader retail distribution.

The company’s core investments are its ownership stakes in Milk Makeup and Obagi Skincare, which together form the foundation of its long-term growth strategy. Emerging areas of focus include science-backed skincare innovation, consumer data analytics, and digital-first brand engagement. No material investments outside its core beauty portfolio have been publicly disclosed, and information on future acquisition targets remains inconclusive based on available public sources.

Geographic Footprint

Waldencast plc maintains its corporate presence across North America and Europe, with executive offices in New York and London. The company’s brands generate the majority of revenue in the United States, which is the largest market for both Milk Makeup and Obagi Skincare, particularly within specialty retail and dermatology channels.

Internationally, Waldencast has an established presence in Europe, Asia-Pacific, and parts of Latin America through a combination of direct operations and distributor relationships. Obagi Skincare has notable penetration in international physician-dispensed markets, while Milk Makeup’s international footprint is expanding through global beauty retailers and localized e-commerce platforms.

Leadership & Governance

Waldencast is led by an executive team with extensive experience in global beauty, consumer products, and finance. The leadership philosophy emphasizes disciplined brand building, scientific credibility, and long-term value creation supported by operational rigor and selective capital allocation.

Key executives include:

  • Michel BroussetFounder & Chief Executive Officer
  • Hind SebtiChief Financial Officer
  • Iris YenChief Growth Officer

The company operates under a board-governed structure typical of publicly listed companies, with oversight informed by public market governance standards and strategic input from directors with backgrounds in beauty, healthcare, and consumer brand development.

Data complied by narrative technology. May contain errors

Top Tech Stocks
See All »
B
NVDA NASDAQ $180.25
B
AAPL NASDAQ $250.12
B
MSFT NASDAQ $395.55
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $126.52
B
Top Financial Stocks
See All »
B
B
JPM NYSE $283.44
B
V NYSE $307.14
Top Energy Stocks
See All »
B
ENB.TO TSX $73.47
B
ENB NYSE $54.08
Top Health Care Stocks
See All »
B
LLY NYSE $985.08
B
JNJ NYSE $241.52
B
AMGN NASDAQ $366.21
Top Real Estate Stocks
See All »
B
PLD NYSE $131.75